Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Q4 2025 earnings call recap: 2026 revenue guidance, TearCare reimbursement milestone, OMNI growth outlook, margins and risks—read now.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including ...

Q4 2025 Management View CEO Mary Szela reported that "our results for both the fourth quarter and the full year were strong. Fourth quarter revenues were $13.2 million, and full year revenues were $45 ...

Every life sciences company knows that patient safety is non negotiable, but the way safety is managed—and the value ...

The Triangle’s life sciences sector is in the midst of one of the most significant growth waves in its history. But as the ...

AICA currently supports auditing against 21 CFR Parts 11, 211, and 600, each mapped at the section and subsection levels.

Add Yahoo as a preferred source to see more of our stories on Google. South Korea–based biotech firm 3billion plans to open a 13,000-square-foot AI-driven genetic testing lab in North Austin, a ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund ...

Every year, AIP awards physical scientists for their leadership and excellence. In recognition of women in the physical ...